Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)

Clinical trial NCT07264166 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07264166
Sponsor: Healing Hope International
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Hypoxic Brain Damage Hypoxic Ischaemic Encephalopathy (HIE)Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest Hypoxic Ischemic Encephalopathy of Newborn Cerebral Palsy Cerebral Palsy (CP)Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment Cerebral Palsy Quadriplegic Cerebral Palsy Spastic Diplegia

Start date: 2026-03-01
Primary completion: 2032-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.